Health; discrimination by certain entities against individuals who refuse certain immunizations, drugs, or facial coverings for reasons of conscience prohibited; civil cause of action for violations provided; Attorney General authorized to defend an entity subject to related federal penalties
HB12, titled the Alabama Conscientious Right to Refuse Act, would prohibit a range of entities from discriminating against individuals who decline certain immunizations, drugs, or facial coverings for reasons of conscience, including religious convictions. The bill applies to employers and prospective employers, places of public accommodation, hospitals, health plan insurers, and occupational licensing boards. It defines the covered refusals broadly to include biologic, DNA-based, gene-editing, pharmaceutical, RNA-based products, and vaccines, and it also addresses refusal to wear facial coverings.
In employment, the bill bars adverse treatment in hiring, promotion, discharge, compensation, training, and other terms or conditions of employment based on a person’s conscientious refusal. In public accommodations, it prohibits denial or restriction of equal access based on immunization status or refusal to wear a facial covering. In the health-care and insurance context, it bars hospitals and insurers from denying care, imposing financial penalties, or restricting coverage, payments, reimbursements, or claims because of a person’s refusal, including refusals made on behalf of an unemancipated minor by a parent or guardian. The bill also prevents occupational licensing boards from denying, suspending, revoking, or refusing to issue or renew a license based on immunization status.
The bill would create private rights of action allowing affected individuals to seek preliminary or permanent injunctions in circuit court, with possible awards of penalties, attorney fees, costs, and expert fees. It also authorizes the Attorney General to enforce the act and to defend or participate in lawsuits on behalf of covered entities that face federal fines, penalties, or mandates because of compliance with the act or because of conflicts between state and federal requirements. The act is set to take effect on June 1, 2026.
The overall sentiment in the available record appears supportive of the bill’s stated purpose, but the bill is still pending committee action and there are no recorded votes or committee transcripts to show broader debate. The sponsor list and the bill’s framing suggest an emphasis on conscience and religious liberty, especially in the context of vaccination and masking policies.
The main points of contention likely center on the breadth of the protections and the potential conflict with federal requirements or private-sector policies. Possible concerns include how the bill would affect workplace safety rules, hospital infection-control practices, insurance administration, public-accommodation policies, and professional licensing standards. The bill’s explicit authorization for the Attorney General to defend entities against federal penalties indicates the drafters anticipated preemption or compliance disputes.
HB12 would add new state-law protections against discrimination based on conscientious refusal of specified medical interventions and facial coverings, affecting employment, public accommodations, health care, insurance, and occupational licensing. It would create enforceable duties for private employers, businesses open to the public, hospitals, insurers, and licensing boards, while also establishing private injunctive relief and state enforcement authority through the Attorney General. The bill would likely interact with existing civil rights, health, insurance, and licensing statutes by imposing new limits on when these entities may consider immunization status or refusal of covered items.
The available materials show no recorded floor or committee vote and no transcript of debate, so there is no documented opposition or support beyond the bill’s introduction and referral status. Based on the bill text and caption, the measure is framed positively around conscience rights and religious convictions, suggesting its sponsors view it as a civil-liberties and anti-discrimination bill. Because it remains pending in committee, the public legislative sentiment cannot be fully measured from the record provided.
Likely areas of contention include the bill’s broad definition of covered products and conduct, its application to hospitals and insurers, and its potential conflict with federal mandates or workplace and public-health requirements. Opponents could argue that it limits employers’ and health-care providers’ ability to manage safety, infection control, and coverage decisions, while supporters would likely emphasize religious freedom, bodily autonomy, and protection from coercive vaccination or masking policies. The Attorney General’s role in defending entities against federal penalties also signals anticipated legal conflict over preemption and compliance.